Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 2
2021 5
2022 3
2023 7
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Can STEreotactic Body Radiation Therapy (SBRT) Improve the Prognosis of Unresectable Locally Advanced Pancreatic Cancer? Long-Term Clinical Outcomes, Toxicity and Prognostic Factors on 142 Patients (STEP Study).
Comito T, Massaro M, Teriaca MA, Franzese C, Franceschini D, Navarria P, Clerici E, Di Cristina L, Bertolini A, Tomatis S, Reggiori G, Bresolin A, Bozzarelli S, Rimassa L, Bonifacio C, Carrara S, Santoro A, Zerbi A, Scorsetti M. Comito T, et al. Among authors: teriaca ma. Curr Oncol. 2023 Jul 24;30(7):7073-7088. doi: 10.3390/curroncol30070513. Curr Oncol. 2023. PMID: 37504373 Free PMC article.
Total tumor volume as a predictor of survival in patients with multiple oligometastases treated with stereotactic ablative radiotherapy (SABR).
Franzese C, Vernier V, Franceschini D, Comito T, Navarria P, Clerici E, Teriaca MA, Massaro M, Di Cristina L, Marini B, Galdieri C, Mancosu P, Tomatis S, Scorsetti M. Franzese C, et al. Among authors: teriaca ma. J Cancer Res Clin Oncol. 2023 Sep;149(12):10495-10503. doi: 10.1007/s00432-023-04964-z. Epub 2023 Jun 6. J Cancer Res Clin Oncol. 2023. PMID: 37280407
Adaptive Volumetric-Modulated Arc Radiation Therapy for Head and Neck Cancer: Evaluation of Benefit on Target Coverage and Sparing of Organs at Risk.
Franzese C, Tomatis S, Bianchi SP, Pelizzoli M, Teriaca MA, Badalamenti M, Comito T, Clerici E, Franceschini D, Navarria P, Di Cristina L, Dei D, Galdieri C, Reggiori G, Mancosu P, Scorsetti M. Franzese C, et al. Among authors: teriaca ma. Curr Oncol. 2023 Mar 13;30(3):3344-3354. doi: 10.3390/curroncol30030254. Curr Oncol. 2023. PMID: 36975467 Free PMC article.
Predictive value of clinical and radiomic features for radiation therapy response in patients with lymph node-positive head and neck cancer.
Franzese C, Lillo S, Cozzi L, Teriaca MA, Badalamenti M, Di Cristina L, Vernier V, Stefanini S, Dei D, Pergolizzi S, De Virgilio A, Mercante G, Spriano G, Mancosu P, Tomatis S, Scorsetti M. Franzese C, et al. Among authors: teriaca ma. Head Neck. 2023 May;45(5):1184-1193. doi: 10.1002/hed.27332. Epub 2023 Feb 23. Head Neck. 2023. PMID: 36815619
Stereotactic radiation therapy for oligometastatic esophagogastric adenocarcinoma: outcome and prognostic factors.
Franceschini D, Teriaca MA, Di Cristina L, Vernier V, Lo Faro L, Franzese C, Comito T, Clerici E, Bellu L, Dominici L, Spoto R, Massaro M, Navarria P, Scorsetti M. Franceschini D, et al. Among authors: teriaca ma. Br J Radiol. 2023 Mar 1;96(1144):20220771. doi: 10.1259/bjr.20220771. Epub 2023 Mar 3. Br J Radiol. 2023. PMID: 36809197 Free PMC article.
Stereotactic Radiotherapy after Incomplete Transarterial (Chemo-) Embolization (TAE\TACE) versus Exclusive TAE or TACE for Treatment of Inoperable HCC: A Phase III Trial (NCT02323360).
Comito T, Loi M, Franzese C, Clerici E, Franceschini D, Badalamenti M, Teriaca MA, Rimassa L, Pedicini V, Poretti D, Solbiati LA, Torzilli G, Ceriani R, Lleo A, Aghemo A, Santoro A, Scorsetti M. Comito T, et al. Among authors: teriaca ma. Curr Oncol. 2022 Nov 16;29(11):8802-8813. doi: 10.3390/curroncol29110692. Curr Oncol. 2022. PMID: 36421345 Free PMC article. Clinical Trial.
The impact of stereotactic ablative radiotherapy on oligoprogressive metastases from renal cell carcinoma.
Franzese C, Marini B, Baldaccini D, Badalamenti M, Navarria P, Bellu L, Franceschini D, Comito T, Clerici E, Teriaca MA, Massaro M, Di Cristina L, Lo Faro L, Tomatis S, Scorsetti M. Franzese C, et al. Among authors: teriaca ma. J Cancer Res Clin Oncol. 2023 Jul;149(8):4411-4417. doi: 10.1007/s00432-022-04352-z. Epub 2022 Sep 15. J Cancer Res Clin Oncol. 2023. PMID: 36109401
16 results